With ongoing concerns about the safety and formulation of compounded GLP-1s, Annie Lambert, PharmD, BCSCP, added her expert insights into the recent crackdown of these products.
Annie Lambert, PharmD, BCSCP
Advertisement
Annie Lambert, PharmD, BCSCP, Clinical Program Manager for Compliance Solutions at Wolters Kluwer.
Articles by Annie Lambert, PharmD, BCSCP
Annie Lambert, PharmD, BCSCP, discusses pharmacies’ regulation and compliance needs when it comes to dispensing compounded GLP-1s.
Annie Lambert, PharmD, BCSCP, discusses the key approaches to ensuring safe and effective dispensing of compounded GLP-1 medications.
Annie Lambert, PharmD, BCSCP, discusses compliance solutions and the common gaps existing in the pharmacy compounding industry today.
Pharmacy leaders have leveraged their experience, their role in interdisciplinary teams, and technology to quickly reinvent approaches to manage long-standing issues exacerbated by the pandemic.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves First At-Home Starting Dose for Leqembi in Early Alzheimer Disease
2
Retail Closures Threaten Pharmacy Access in Vulnerable Communities
3
Emerging Market Access Models Reshapes Drug Distribution
4
Q&A: How AI Is Reshaping the Pharmacist's Role in Medication Safety
5